Search - tctmd.com

Displaying 41 - 52 of 52

Sort: Relevancy | Date

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Presenter: Pascal Vranckx

October 31, 2013

Presentation TCT 2013

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Presenter: Christopher Granger

October 27, 2013

Presentation Fellows 2013

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: Manesh Patel

April 16, 2013

Presentation TCT 2013

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Presenter: Andr?s Kom?csi, Andr?s Vorobcsuk, D?niel Kehl, Daniel Aradi

January 31, 2013

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Contrarian Position: Oral Anticoagulants Introduce More Problems Than They Solve!

Presenter: Greg Mishkel

October 24, 2012

Presentation

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Presenter: Francesco Dentali

October 18, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

Advertisement

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Part 1: Oral Anticoagulants

Contrarian Position: Oral Anticoagulants Introduce More Problems Than They Solve!

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

New Oral Anticoagulants for Stroke Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content